Profil

PITCHOT William

Autres Services Médicaux > Service de psychiatrie

See author's contact details
Main Referenced Co-authors
Ansseau, Marc  (137)
Hansenne, Michel  (58)
Scantamburlo, Gabrielle  (42)
Pinto, Emmanuel  (32)
Reggers, Jean  (25)
Main Referenced Keywords
Humans (38); Adult (27); Male (25); Female (23); Middle Aged (15);
Main Referenced Unit & Research Centers
Centre de Neurosciences Cognitives et Comportementales - ULiège [BE] (8)
Centre de Neurosciences Comportementale et Cognitive (4)
Main Referenced Disciplines
Psychiatry (161)
Neurosciences & behavior (25)
Treatment & clinical psychology (19)
Neurology (10)
Theoretical & cognitive psychology (4)

Publications (total 207)

The most downloaded
20503 downloads
DEBRUN, A., & PITCHOT, W. (2009). Impact des antidépresseurs au niveau pondéral. Acta Psychiatrica Belgica. https://hdl.handle.net/2268/194820

The most cited

260 citations (Scopus®)

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., & Legros, J.-J. (May 2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32 (4), 407-410. doi:10.1016/j.psyneuen.2007.01.009 https://hdl.handle.net/2268/6401

Souery, D., & Pitchot, W. (2022). Switching antidepressants in patients with treatment-resistant depression. In Managing Treatment-Resistant Depression: Road to Novel Therapeutics. Elsevier. doi:10.1016/B978-0-12-824067-0.00010-4
Editorial reviewed

Ansseau, M., Scantamburlo, G., & PITCHOT, W. (2017). Antidépresseurs. In J. Guelfi & F. Rouillon, Manuel de Psychiatrie (pp. 603-614). Issy-les-Moulineaux, France: Elsevier Masson.
Peer reviewed

Wagener, A., Thirion, J., PITCHOT, W., & Blairy, S. (January 2016). "Quand voyager mentalement dans le temps est difficile) - Une étude comparative des souvenirs et projections définissant le soi chez des patients dépressifs et des sujets contrôles sains [Poster presentation]. 14ème Congrès de l'Encéphale, Paris, France.

Laloyaux, J., Levaux, M.-N., Van der Linden, M., Domken, M.-A., PITCHOT, W., & Laroi, F. (2016). Projet Neworld : Evaluation informatisée des capacités de multitâche en neuropsychiatrie [Poster presentation]. 14e Congrès de l’Encéphale, Paris, France.

Wagener, A., Boulanger, M., PITCHOT, W., & Blairy, S. (October 2015). Les souvenirs définissant le soi dans le trouble dépressif majeur unipolaire : Pourquoi les évoquer durant l’entretien clinique ? Acta Psychiatrica Belgica, 116 (2), 27-34.
Peer Reviewed verified by ORBi

PITCHOT, W. (2015). Dépression majeure et prescription personnalisée. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W. (2015). Stress au travail et affections cardio-vasculaires: un lien fort. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Souery, D., Calati, R., Montgomery, S., Kasper, S., Zohar, J., PITCHOT, W., Mendlewicz, J., & Serretti, A. (2015). What to expect from a third step in treatment resistant depression: a prospective study. World Journal of Biological Psychiatry. doi:10.3109/15622975.2014.987814
Peer Reviewed verified by ORBi

PITCHOT, W. (2015). Le traitement personnalisé des troubles de l'humeur: mythe ou réalité? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2015). La stigmatisation des maladies mentales. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2015). Stigmatisation de la dépression: comment s'y adapter. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

LUPPENS, D., PIETTE, C., RADERMECKER, R., SCANTAMBURLO, G., ANSSEAU, M., & PITCHOT, W. (November 2014). Dépression et diabète de type 2. Analyse étiopathogènique d'une comorbidité fréquente. Revue Médicale de Liège, 69 (11), 611-617.
Peer reviewed

DAVIN, L., LEGRAND, V., LANCELLOTTI, P., PIERARD, L., & PITCHOT, W. (2014). When the heart has its reason: the Takotsubo Syndrome. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). Le bonheur: liberté ou dictature? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). Le suicide chez la personne âgée. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W. (2014). La réforme de la psychothérapie: quel avantage pour le patient? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). Duloxetine effective for eisotrophobia. Primary Care Companion to the Journal Clinical Psychiatry.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). Actualités dans le traitement pharmacologique des troubles anxieux. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W., Moeremans p, Vankeirsbilck A, & Vandenberghe T. (2014). Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on quality of life of gp -based management of antipsychotic treatment in Belgium. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). Pourquoi la psychiatrie est-elle si peu désirable? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2014). indications curative et préventive du lithium dans le trouble bipolaire. Annales Médico-Psychologiques.
Peer Reviewed verified by ORBi

Bauer, M., Del'Osso, L., Kasper, S., PITCHOT, W., Denker-Vansvik, E., Kohler, J., Jorgensen, L., & Montgomery, S. (2013). Extends-Release quetiapine fumarate mono therapy and quetiapine XR or lithium add-on to antidepressants in patients with treatment-resistant major depressive disorder. Journal of Affective Disorders.
Peer Reviewed verified by ORBi

PITCHOT, W., & Toussaint I. (2013). Le désordre hypersexuel ne figurera pas dans le DSM-V: Analyse contextuelle. Revue Médicale de Liège.
Peer reviewed

SCHEEN, A., & PITCHOT, W. (2013). Le praticien face aux addictions dans tous leurs etats. Revue Médicale de Liège, 68 (5-6), 209-10.
Peer reviewed

SCANTAMBURLO, G., PITCHOT, W., & Ansseau, M. (2013). La dependance affective. Revue Médicale de Liège, 68 (5-6), 340-7.
Peer reviewed

PITCHOT, W. (2013). Antidépresseurs et syndrome d'interruption. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2013). Vers la création de nouveaux partenariats. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2013). Quelle drôle d'époque où on se préoccupe plus du moral des marchés que de celui de la population. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2013). Les antidépresseurs dans la dépression majeure: La dose a-t-elle de l'importance? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2013). La psychiatrie clinique est-elle en danger? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2013). Le médicament du mois - L'asénapine. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W. (2013). Y-a-t-il de la place pour le désespoir du médecin dans le traitement de la dépression? Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., SCANTAMBURLO, G., & Souery d. (2013). Des antipsychotiques dans la dépression. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., SCANTAMBURLO, G., Pinto, E., & Karila L. (2013). Addiction à la cocaine. Revue Médicale de Liège.
Peer reviewed

BAKAY, S., IWEINS, A., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2013). Comment je traite ...la prise en charge de l'agitation en urgence. Revue Médicale de Liège, 68 (11), 553-6.
Peer reviewed

Gijsen P, Jammaer R, Mourad H, & PITCHOT, W. (2013). Le jeu pathologique: Evolution conceptuelle, caractéristiques cliniques et perspectives psychothérapeutiques. Revue Médicale de Liège.
Peer reviewed

Denis C, jacquart J, & PITCHOT, W. (2013). Mutismes. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., & SCANTAMBURLO, G. (2013). Comment s'adapter à la mauvaise réputation de la dépression? Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2013). Complications psychiatriques et addictions. Revue Médicale de Liège, 68 (5-6), 218-20.
Peer reviewed

PITCHOT, W. (2012). Comment allons-nous? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W., Constant E, Floris M, Kornreich C, & Souery D. (2012). Les antipsychotiques atypiques dans la dépression résistante. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2012). Stigmatisation des maladies mentales. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2012). Les IMAO dans la dépression résistante ou le retour aux vieilles recettes. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

LICITSYNA, O., Ansseau, M., GERNAY, D., PITCHOT, W., & Bertrand, J. (2012). Sexual dysfunction induced by antidepressants and antipsychotics. Terapevticheskii Arkhiv, 84 (10), 103-8.
Peer Reviewed verified by ORBi

BAKAY, S., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2012). L'image du mois. Ingestion volontaire de corps etrangers: aspects psychiatriques. Revue Médicale de Liège, 67 (3), 105-106.
Peer reviewed

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2012). Approche clinique et therapeutique de la depression chez la personne agee. Revue Médicale de Liège, 67 (11), 566-72.
Peer reviewed

Schlaepfer, T., Agren, H., Monteleone, P., Gasto, C., PITCHOT, W., Rouillon, F., Nutt, D., & Kasper, S. (2012). The hidden third: Improving outcome in treatment-resistant depression. Journal of Psychopharmacology. doi:10.1177/0269881111431748
Peer Reviewed verified by ORBi

De Fruyt, J., Deschepper, E., Audenaert, K., Constant, E., Floris, M., PITCHOT, W., sienaert, P., Souery, D., & Claes, S. (2012). Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis. Journal of Psychopharmacology. doi:10.1177/0269881111408461
Peer Reviewed verified by ORBi

PITCHOT, W., & Ansseau, M. (2012). Efficacy of quetiapine in treatment-resistant panic disorder: a case report. Asian Journal of Psychiatry, 5 (2), 204-205. doi:10.1016/j.ajp.2012.02.013
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., Ansseau, M., & Souery, D. (2012). Le trouble bipolaire: une affection bien complexe. Revue Médicale de Liège, 67 (5-6), 366-373.
Peer reviewed

Ansseau, M., & PITCHOT, W. (2012). Les antidépresseurs. In F. Rouillon (Ed.), Manuel de Psychiatrie (2ème édition, pp. 575-586). Elsevier Masson.

DEBABECHE, C., Ansseau, M., & PITCHOT, W. (2012). Etat de stress post-traumatique et debriefing psychologique: un sujet controverse. Revue Médicale de Liège, 67 (1), 11-5.
Peer reviewed

Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Effets secondaires sexuels des antidépresseurs. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W. (2011). Hair loss associated with escitalopram but not venlafaxine. Primary Care Companion to the Journal Clinical Psychiatry. doi:10.4088/PCC.11l01146
Peer Reviewed verified by ORBi

Tassin, S., Bragard, I., THOMMESSEN, M., & PITCHOT, W. (2011). Aspects psycho-sociaux du cancer du sein. Revue Médicale de Liège, 66 (5-6), 315-319.
Peer reviewed

PITCHOT, W., SOUERY, D., & Ansseau, M. (2011). La dépression résistante : Définition et diagnostic. Acta Psychiatrica Belgica, 111 (4), 13-19.
Peer Reviewed verified by ORBi

PITCHOT, W., & Pinto, E. (2011). Réunion de consensus sur la procédure de mise en observation. Acta Psychiatrica Belgica, 211.
Peer Reviewed verified by ORBi

PITCHOT, W. (2011). Construisons des ponts entre la science et la pratique: intérêt d'un cas clinique. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). La dépression résistante : Définition et diagnostique. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PIERARD, G., & PITCHOT, W. (2011). Ce que les psychiatres devraient savoir sur les effets indésirables cutanés des psychotropes. Acta Psychiatrica Belgica, 11, 4-7.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Le cas clinique du mois. Syndrome sérotoninergique induit par une association isoniazide/venlafaxine. Revue Médicale de Liège, 66 (12), 611-613.
Peer reviewed

HAIDON, M., PIETTE, C., ANSSEAU, M., & PITCHOT, W. (2011). Les troubles psychotiques dans les démences : quand la psychiatrie croise la neurologie. Acta Psychiatrica Belgica, 111 (11), 22-28.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Les antidépresseurs du futur : rôle du système glutamatergique. Revue Médicale de Liège, 66 (4), 195-198.
Peer reviewed

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). Les antidépresseurs tricycliques et les IMAO ont-ils encore une place dans le traitement de la dépression? Revue Médicale de Liège.
Peer reviewed

DEBABECHE, C., PIETTE, C., Ansseau, M., & PITCHOT, W. (2011). Le coma psychogène. Acta Psychiatrica Belgica, 111 (3), 20-25.
Peer Reviewed verified by ORBi

Goodwin, G., Abbar, M., Schlaepfer, T., Grunze, H., Licht, R., Bellivier, F., Fountoulakis, F., Altamura, C., PITCHOT, W., Agren, H., Holsboer-traschler, E., & Vieta, E. (2011). Aripiprazole in patients with bipolar disorder: An update of practical guidance. Current Medical Research and Opinion.
Peer Reviewed verified by ORBi

PITCHOT, W., & PIETTE, C. (2011). Le bupropion dans le traitement de la fibromyalgie: a propos d'un cas. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Dysfonctions sexuelles et antidépresseurs. Revue Médicale de Liège, 66 (2), 69-74.

PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2010). Duloxetine in major depressed patients resistant to SSRI and/or venlafaxine. Psychiatria Danubina.
Peer Reviewed verified by ORBi

Farcy, L., PIETTE, C., MAVROPOULOS, G., Pinto, E., Ansseau, M., & PITCHOT, W. (2010). Delirium et anorexie. Acta Psychiatrica Belgica, 110, 3-7.
Peer Reviewed verified by ORBi

Pitchot, W., & Ansseau, M. (2010). Aripiprazole, hypertension, and confusion. Journal of Neuropsychiatry and Clinical Neurosciences, 22 (1), 123.E33. doi:10.1176/appi.neuropsych.22.1.123-t.e33
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2010). Guérir la dépression : une question d'objectif et de détermination. Revue Médicale de Liège, 65 (5-6), 370-380.
Peer reviewed

Scantamburlo, G., Reggers, J., Hansenne, M., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2010). Ocytocine plamsatique et dimensions de personnalité dans la dépression unipolaire. Encéphale (L'), 36, 17.
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? Alcohol, 43 (4), 271-5. doi:10.1016/j.alcohol.2009.02.006
Peer reviewed

Pitchot, W., & Ansseau, M. (2009). Dependance au zolpidem et crise d'epilepsie. Revue Médicale de Liège, 64 (7-8), 407-8.
Peer reviewed

DEBRUN, A., & PITCHOT, W. (2009). Impact des antidépresseurs au niveau pondéral. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Floris, M., PITCHOT, W., Scantamburlo, G., Constant, E., & Huysse, S. (2009). Aspects cliniques de la dépression en tant que maladie : intérêt d'atteindre la rémission et conséquences thérapeutiques. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., Constant, E., Floris, M., & Huysse, S. (2009). Nouveaux développement dans le traitement de la dépression. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Constant, E., PITCHOT, W., Floris, M., Scantamburlo, G., & Huysse, X. (2009). Neuroplasticité, neurogenèse et dépression : Considérations cliniques. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

PITCHOT, W. (2009). Les troubles anxieux. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Zelinka, V., Faymonville, M.-E., Pitchot, W., & Ansseau, M. (2009). L'hypnose dans la prise en charge des douleurs chroniques. Acta Psychiatrica Belgica, 109 (3), 21-28.
Peer Reviewed verified by ORBi

DENIS, C., JACQUART, J., & PITCHOT, W. (2009). Troubles autistiques ou troubles de l'attachement? Une frontière floue et mal définie. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., & SOUERY, D. (2008). Le bonheur est contagieux. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Pitchot, W., Paquay, C., & Ansseau, M. (2008). Le comportement suicidaire: facteurs de risque psychosociaux et psychiatriques. Revue Médicale de Liège, 63, 396-403.
Peer reviewed

Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Dopamine et dépression: le neurotransmetteur oublié. Revue Médicale de Liège, 63, 378-384.
Peer reviewed

Pinto, E., Reggers, J., Gorwood, P., BONI, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008). The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol and Alcoholism, 43, 398-400. doi:10.1093/alcalc/agn015
Peer Reviewed verified by ORBi

Fumal, A., Schoenen, J., Maertens De Noordhout, A., & Pitchot, W. (2008). Therapeutic potential of repetitive transcranial magnetic stimulation in brain. Revue Médicale de Liège, 63 (5-6), 330-337.
Peer reviewed

PITCHOT, W. (2008). Editorial. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Scantamburlo, G., Pitchot, W., Ansseau, M., & Legros, J.-J. (2008). Peptides neurohypophysaires et dépression unipolaire: quel avenir? Revue Médicale de Liège, 63, 385-390.
Peer reviewed

Pitchot, W., & Ansseau, M. (2008). Shock-like sensations associated with duloxetine discontinuation. Annals of Clinical Psychiatry, 20 (3), 175. doi:10.1080/10401230802177664
Peer Reviewed verified by ORBi

Pitchot, W., Polis, M.-H., Belachew, S., & Ansseau, M. (2008). Dépression et neuroplasticité. Revue Médicale de Liège, 63, 372-377.
Peer reviewed

Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Les antidépresseurs dans la dépression bipolaire: attention aux risques. Revue Médicale de Liège, 63, 391-395.
Peer reviewed

Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008). Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior. Journal of Psychiatric Research, 42, 684-688. doi:10.1016/j.jpsychires.2007.07.007
Peer Reviewed verified by ORBi

Pinto, E., Pitchot, W., & Ansseau, M. (2008). Les psychostimulants. Revue Médicale de Liège, 63, 411-416.
Peer reviewed

Ansseau, M., Scantamburlo, G., Pinto, E., & Pitchot, W. (2008). Neurobiologie et pharmacothérapie du trouble obsessionnel-compulsif. Revue Médicale de Liège, 63, 359-363.
Peer reviewed

PITCHOT, W., & SOUERY, D. (2008). L'efficacité des antidépresseurs : notre sens clinique serait-il mauvais? Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., & Legros, J.-J. (May 2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32 (4), 407-410. doi:10.1016/j.psyneuen.2007.01.009
Peer Reviewed verified by ORBi

Pitchot, W., Pinto, E., Scantamburlo, G., & Ansseau, M. (March 2007). Duloxetine in major depressed patients resistant to SSRIs or venlafaxine. European Psychiatry, 22 (Suppl. 1), 242. doi:10.1016/j.eurpsy.2007.01.810
Peer Reviewed verified by ORBi

Ansseau, M., & Pitchot, W. (2007). Les antidépresseurs. In J. D. Guelfi & F. Rouillon (Eds.), Manuel de Psychiatrie (pp. 504-515). Paris, France: Masson.

Pitchot, W., & Ansseau, M. (2007). Nouveautés dans le traitement des troubles de l'humeur. Acta Psychiatrica Belgica, 107, 21-22.
Peer Reviewed verified by ORBi

Pitchot, W., & Ansseau, M. (2007). Hypothalamo-growth hormone dysfunction in panic disorder. Acta Psychiatrica Belgica, 107, 21-22.
Peer Reviewed verified by ORBi

Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4.
Peer reviewed

Pitchot, W., & Ansseau, M. (2007). Les troubles de l'humeur: approche pharmacologique. Revue Médicale de Liège, 62 (S2), 21-4.
Peer reviewed

Scantamburlo, G., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2007). Therapeutic utilisations of vasopressin and oxytocin in mood disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 1, 157-161.
Peer reviewed

Pitchot, W. (November 2006). La duloxetine (Cymbalta). Revue Médicale de Liège, 61 (11), 787-90.
Peer reviewed

Linotte, S., Barreto, M., Van Geit, N., D'haenen, H., Vanderkelen, P., Schepers, N., Scantamburlo, G., Pitchot, W., Ansseau, M., Van der Auwera, K., Bollen, J., Souery, D., & Mendlewicz, J. (September 2006). Clinical characteristics of depressive episodes in Bipolar I and Bipolar II disorders. European Neuropsychopharmacology, 16 (Suppl. 4), 301. doi:10.1016/S0924-977X(06)70314-5
Peer Reviewed verified by ORBi

Zdanowicz, N., Floris, M., PITCHOT, W., Souery, D., & Staner, L. (2006). Psychoses chez l'adolescent et le jeune adulte : Les espoirs dus aux atypiques. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Polis, M.-H., Pitchot, W., & Ansseau, M. (2006). Dépression et neuroplasticité : des découvertes neuroanatomiques aux nouvelles stratégies thérapeutiques. Acta Psychiatrica Belgica, 106 (1), 20-31.
Peer Reviewed verified by ORBi

Scantamburlo, G., Hansenne, M., Fuchs, S., PITCHOT, W., Reggers, J., ANSSEAU, M., & Legros, J.-J. (2006). OXYTOCIN, VASOPRESSIN AND ANXIETY IN MAJOR DEPRESSION: AGO-ANTAGONIST NEUROHROMONES. European Neuropsychopharmacology, 16, 306-S307.
Peer Reviewed verified by ORBi

Pitchot, W., & Ansseau, M. (2006). Rôle des récepteurs 5-HT1A dans le comportement suicidaire. Neurone, 11, 90-94.

Scantamburlo, G., Fuchs, S., Pitchot, W., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). Plasma oxytocin and anxiety in depressed patients. European Neuropsychopharmacology, 15 (Suppl. 3), 430.
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology, 30 (9), 839-845. doi:10.1016/j.psyneuen.2005.04.015
Peer Reviewed verified by ORBi

Pinto, E., Gorwood, P., Reggers, J., Vaira, D., Fuchs, S., & Pitchot, W. (March 2005). Alcohol craving and the A1 allele of the D2 dopamine receptor gene. European Psychiatry, 20 (Suppl. 1), 25.
Peer Reviewed verified by ORBi

Zdanowicz, N., Floris, M., PITCHOT, W., Souery, D., & Staner, L. (2005). L'ADHD : la maladie qui fâche. Acta Psychiatrica Belgica.
Peer Reviewed verified by ORBi

Souery, D., Zdanowicz, N., Floris, M., PITCHOT, W., & Staner, L. (2005). La dépression bipolaire : La face cachée de l'iceberg. Acta Psychiatrica Belgica, 105, 131-139.
Peer Reviewed verified by ORBi

Floris, M., PITCHOT, W., Souery, D., Staner, L., & Zdanowicz, N. (2005). Schizophrenia, sleep and antipsychotics. Acta Psychiatrica Belgica, 105, 195-203.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2005). 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry, 58 (11), 854-8. doi:10.1016/j.biopsych.2005.05.042
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2004). Neurohypophyseal response to apomorphine and clonidine stimulation in major depression. European Neuropsychopharmacology, 14 (Suppl. 3), 291-S292. doi:10.1016/S0924-977X(04)80355-9
Peer Reviewed verified by ORBi

Demyttenaere, K., Pitchot, W., Albert, A., Wagemans, D., & De Cock, P. (October 2004). The use of the PHQ as follow-up instrument for MDD in the primary care setting. European Neuropsychopharmacology, 14 (Suppl. 3), 214.
Peer Reviewed verified by ORBi

Fuchs, S., Reggers, J., Pinto, E., Scantamburlo, G., Pitchot, W., Hansenne, M., Maertens De Noordhout, A., & Ansseau, M. (October 2004). Therapeutic application of right prefrontal low repetitive transcranial magnetic stimulation on depressed patients. European Neuropsychopharmacology, 14 (Suppl. 3), 226. doi:10.1016/S0924-977X(04)80206-2

Pitchot, W., Wauthy, J., Legros, J.-J., & Ansseau, M. (March 2004). Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. European Neuropsychopharmacology, 14 (2), 151-155. doi:10.1016/S0924-977X(03)00108-1
Peer Reviewed verified by ORBi

Demyttenaere, K., Pitchot, W., Albert, A., Zhang, L., & De Cock, P. (September 2003). Diagnosis of depression by the primary care physician and the patient. European Neuropsychopharmacology, 13 (Suppl. 4), 248.
Peer Reviewed verified by ORBi

Pitchot, W., Demyttenaere, K., Albert, A., Zhang, L., & De Cock, P. (September 2003). Impairment in Major Depressive Disorder. European Neuropsychopharmacology, 13 (Suppl. 4), 247.
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Scantamburlo, G., Renard, B., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Harm avoidance is related to mismatch negativity (MMN) amplitude in healthy subjects. Personality and Individual Differences, 34 (6), 1039-1048. doi:10.1016/S0191-8869(02)00088-0
Peer Reviewed verified by ORBi

Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., & Ansseau, M. (2003). Catecholamine and HPA axis dysfunction in depression : relationship with suicidal behavior. Neuropsychobiology, 47 (3), 152-157. doi:10.1159/000070585
Peer Reviewed verified by ORBi

Couvreur, A., Cleinge, L., Wauthy, J., Vaulet, V., Meeremans, C., Tacconi, G., Debaere, T., Ansseau, M., & Pitchot, W. (2003). Le fonctionnement en réseau : une nouvelle vision de soins en santé mentale. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles, (5), 59-67.
Peer reviewed

Hansenne, M., Olin, C., Pinto, E., Pitchot, W., & Ansseau, M. (2003). Event-related potentials to emotional and neutral stimuli in alcoholism. Neuropsychobiology, 48 (2), 77-81. doi:10.1159/000072881
Peer Reviewed verified by ORBi

Braham, C., Paquet, P., Pitchot, W., Pierard, C., & Pierard, G. (2003). Réactions cutanées indésirables aux antidépresseurs. Revue Médicale de Liège, 58 (1), 22-4.
Peer reviewed

Hansenne, M., Pinto, E., Scantamburlo, G., Couvreur, A., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology, 18 (3), 201-5. doi:10.1002/hup.468
Peer Reviewed verified by ORBi

PAQUAY, C., PITCHOT, W., Reggers, J., & ANSSEAU, M. (2003). Dépression, anxiété, agressivité, impulsivité et comportement suicidaire. Acta Psychiatrica Belgica, 103, 161-170.
Peer Reviewed verified by ORBi

Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., & Mormont, C. (October 2002). The transsexual : what about the future ? European Psychiatry, 17 (6), 353-362. doi:10.1016/S0924-9338(02)00703-4
Peer Reviewed verified by ORBi

Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J.-J., & Ansseau, M. (October 2002). Hormonal and temperature responses to the 5-HT1a receptor agonist flesinoxan in normal volunteers. Psychopharmacology, 164 (1), 27-32. doi:10.1007/s00213-002-1177-0
Peer Reviewed verified by ORBi

Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., Cornet, J.-P., & Mormont, C. (August 2002). Comparisons of two groups of sex-change applicants based on the MMPI. Psychological Reports, 91 (1), 233-240. doi:10.2466/pr0.2002.91.1.233
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., & Ansseau, M. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychological Medicine, 32 (5), 935-41. doi:10.1017/S0033291702005445
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Pitchot, W., Reggers, J., Scantamburlo, G., Moor, M., & Ansseau, M. (2002). Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Personality and Individual Differences, 33 (6), 967-977. doi:10.1016/S0191-8869(01)00205-7
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., & Ansseau, M. (2002). Serotonin, personality and borderline personality disorder. Acta Neuropsychiatrica, 14 (2), 66-70. doi:10.1034/j.1601-5215.2002.140203.x
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., PITCHOT, W., Hansenne, M., Fuchs, S., & Ansseau, M. (2002). Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. Psychoneuroendocrinology, 27 (7), 873-879. doi:10.1016/S0306-4530(01)00088-9
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., & Ansseau, M. (November 2001). Role of dopamine in non-depressed patients with a history of suicide attempts. European Psychiatry, 16 (7), 424-427. doi:10.1016/S0924-9338(01)00601-0
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., & Ansseau, M. (October 2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26 (7), 689-696. doi:10.1016/S0306-4530(01)00021-X
Peer Reviewed verified by ORBi

PITCHOT, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., & Ansseau, M. (April 2001). Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology, 26 (3), 331-335. doi:10.1016/S0306-4530(00)00047-0
Peer Reviewed verified by ORBi

PITCHOT, W. (2001). La dopamine dans les troubles de l'humeur. Neurone, 6 (8), 255-258.

PITCHOT, W., & ANSSEAU, M. (2001). Venlafaxine induced hair loss. American Journal of Psychiatry. doi:10.1176/appi.ajp.158.7.1159-a
Peer Reviewed verified by ORBi

PITCHOT, W., & ANSSEAU, M. (2001). Adding olanzapine to venlafaxine in treatment-refractory non-psychotic chronic depression. American Journal of Psychiatry.
Peer Reviewed verified by ORBi

David, C., WAUTHY, J., Vaulet, V., Frognet, E., Franck, N., PITCHOT, W., & ANSSEAU, M. (2001). Le médicament parmi les thérapies relationnelles : Enquête et réflexions. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles.
Peer reviewed

PITCHOT, W., & ANSSEAU, M. (2001). Reply to Letter to the Editor. Psychoneuroendocrinology.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2001). Alpha-2-adrenoreceptors in depressed suicide attempters : relationship with medical lethality of the attempt. Neuropsychobiology, 44 (2), 91-94. doi:10.1159/000054923
Peer Reviewed verified by ORBi

Pitchot, W., Herrera, C., & Ansseau, M. (2001). Hpa Axis Dysfunction in Major Depression: Relationship to 5-Ht(1a) Receptor Activity. Neuropsychobiology, 44 (2), 74-7. doi:10.1159/000054919
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2
Peer Reviewed verified by ORBi

ANSSEAU, M., & PITCHOT, W. (1998). Dépression et suicide : Aspects biologiques. Neuro-psy.
Peer reviewed

Herrera, C., & PITCHOT, W. (1998). Effet de l'hypercortisolémie sur la sensibilité des récepteurs 5-HT1A dans la dépression majeure. Neurone.

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Machurot, P. Y., & Ansseau, M. (1998). The tridimensional personality questionnaire (TPQ) and depression. European Psychiatry, 13 (2), 101-3. doi:10.1016/S0924-9338(98)80026-6
Peer Reviewed verified by ORBi

Hansenne, M., PITCHOT, W., Papart, P., & ANSSEAU, M. (1998). Serotonergic modulation of the P300 event related brain potential. Human Psychopharmacology, 13 (4), 239-243. doi:10.1002/(SICI)1099-1077(199806)13:4<239::AID-HUP986>3.0.CO;2-V
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Moreno, A. G., Reggers, J., Machurot, P.-Y., & Ansseau, M. (1997). Harm avoidance dimension of the Tridimensional Personality Questionnaire and serotonin-1A activity in depressed patients. Biological Psychiatry, 42 (10), 959-61. doi:10.1016/S0006-3223(97)00325-9
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Moreno, A. G., & Ansseau, M. (1996). Growth hormone response to apomorphine in obsessive-compulsive disorder. Journal of Psychiatry and Neuroscience, 21 (5), 343-5.
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Zaldua, I. U., & Ansseau, M. (1996). Suicidal behavior in depressive disorder: an event-related potential study. Biological Psychiatry, 40 (2), 116-22. doi:10.1016/0006-3223(95)00372-X
Peer Reviewed verified by ORBi

Pitchot, W., & Ansseau, M. (November 1995). Le cas clinique du mois. Dépression majeure chez un patient diabétique. Revue Médicale de Liège, 50 (11), 451-452.
Peer reviewed

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., & Hansenne, M. (1995). Responses to mCPP stimulation in depressed patients. American Journal of Psychiatry, 152 (12), 1834; author reply 1834-5. doi:10.1176/ajp.152.12.1834
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts. Biological Psychiatry, 38 (3), 201-203. doi:10.1016/0006-3223(95)00147-9
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). The dexamethasone suppression test in violent suicide attempters with major depression. Biological Psychiatry, 37 (4), 273-274. doi:10.1016/0006-3223(94)00228-U
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Timsit-Berthier, M., & Ansseau, M. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology, 96 (2), 194-196. doi:10.1016/0168-5597(94)00317-8
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Effect of previous antidepressant therapy on the growth hormone response to apomorphine. Neuropsychobiology, 32 (1), 19-22. doi:10.1159/000119207
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Lembreghts, M., Hansenne, M., Wauthy, J., Reel, C., Jammaer, R., Papart, P., Sulon, J., & Legros, J.-J. (1995). The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 28 (Suppl. 2), 91-92. doi:10.1055/s-2007-979625
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Wauthy, J., & Ansseau, M. (1995). Bases biologiques du comportement suicidaire: approche neuroendocrinienne et psychophysiologique du role des catecholamines. Acta Psychiatrica Belgica, 95 (4-5), 210-233.
Peer Reviewed verified by ORBi

Charles, G., Hansenne, M., Ansseau, M., Pitchot, W., Machowski, R., Schittecatte, M., & Wilmotte, J. (1995). P300 in posttraumatic stress disorder. Neuropsychobiology, 32 (2), 72-74. doi:10.1159/000119216
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., & Gonzalez Moreno, A. (1994). Anxiolytic activity of single doses of the 5-HT3 antagonist zacopride. European Neuropsychopharmacology, 4 (3), 355. doi:10.1016/0924-977X(94)90177-5
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Wauthy, J., Hansenne, M., & von Frenckell, R. (1994). Relationship between alpha 2-adrenergic function and suicidal behavior in depressed patients. Psychiatry Research, 52 (2), 115-123. doi:10.1016/0165-1781(94)90081-7
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Gonzalez Torrecilas, J., Mirel, J., & Ansseau, M. (1994). Psychophysiological correlates of suicidal behavior in depression. A preliminary study. Neuropsychobiology, 30 (1), 1-3. doi:10.1159/000119125
Peer Reviewed verified by ORBi

Ansseau, M., PITCHOT, W., Hansenne, M., WAUTHY, J., Moreno, A. G., Jammaer, R., Réel, C., Lembreghts, M., Papart, P., Gros-Gean, J., Devroye, A., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge and suicidal behavior. European Neuropsychopharmacology, 4 (3), 322-323. doi:10.1016/0924-977X(94)90138-4
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Wauthy, J., Moreno, A. G., Hansenne, M., Lembreghts, M., Jammaer, R., Réel, C., Gros-Gean, J., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge in major depression. European Neuropsychopharmacology, 4 (3), 321-322. doi:10.1016/0924-977X(94)90137-6
Peer Reviewed verified by ORBi

Schittecatte, M., Charles, G., Machowski, R., Dumont, F., Garcia-Valentin, J., Wilmotte, J., Papart, P., PITCHOT, W., WAUTHY, J., Ansseau, M., Pelc, I., & Hoffman, G. (1994). Effect of gender and diagnostic on growth hormone response to clonidine for major depression : A large scale multicenter study. American Journal of Psychiatry, 151 (2), 216-220. doi:10.1176/ajp.151.2.216
Peer Reviewed verified by ORBi

Pitchot, W., Gonzalez Moreno, A., Hansenne, M., Wauthy, J., & Ansseau, M. (1993). Role du systeme dopaminergique dans la depression: correlats cliniques du test a l'apomorphine. Acta Psychiatrica Belgica, 93 Spec No, 343-358.
Peer Reviewed verified by ORBi

ANSSEAU, M., Jammaer, R., Réel, C., Wauthy, J., Lembreghts, M., PITCHOT, W., Moreno, A. G., Sulon, J., & Legros, J.-J. (1993). Effect of pindolol on the neuroendocrine and temperature responses to flesinoxan. European Neuropsychopharmacology, 3 (3), 368. doi:10.1016/0924-977X(93)90154-E
Peer Reviewed verified by ORBi

Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1993). Mesure subjective de l'impact d'un évènement : Traduction française et validation de l'échelle d’Horowitz. Psychologie Médicale, 25 (1), 86-88.
Peer reviewed

Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., & Ansseau, M. (1993). Mesure subjective de l'impact d'un événement : traduction française et adaptation de l'échelle d'Horowitz. Psychologie Médicale, 25 (1), 86-88.
Peer reviewed

Machurot, P.-Y., Hansenne, M., Pitchot, W., Gonzalez Moreno, A., & Ansseau, M. (1993). L'état de stress post-traumatique chez les brûlés : Une revue. Acta Psychiatrica Belgica, 93 Spec No, 359-367.
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, A., Papart, P., & WAUTHY, J. (1993). Pilot study of flesinoxan in major depression. Effect on REM latency and body temperature. Human Psychopharmacology, 8 (4), 279-283. doi:10.1002/hup.470080407
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Papart, P., Gonzalez Moreno, A., Timsit-Berthier, M., & LEGROS, J.-J. (1993). Intérêt des marqueurs biologiques de dépression dans le choix du traitement antidépressif. Médecine et Hygiène, 51 (1990), 1970-1976.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry, 31 (12), 1213-1219. doi:10.1016/0006-3223(92)90340-6
Peer Reviewed verified by ORBi

Ansseau, M., Pitchot, W., Papart, P., Gonzalez Moreno, A., Lembreghts, M., & Legros, J.-J. (1992). Neuroendocrine Factors in Affective Disorders. Clinical Neuropharmacology, 15 (Suppl 1 Pt A), 574A-575. doi:10.1097/00002826-199201001-00299
Peer Reviewed verified by ORBi

ANSSEAU, M., Lembreghts, M., Jammaer, R., Réel, C., Wauthy, J., PITCHOT, W., Gonzalez, M. A., Sulon, J., Legros, J.-J., & Bradford, L. D. (1992). Neuroendocrine responses to intravenous flesinoxan as an index of serotonergic neurotransmission. European Neuropsychopharmacology, 2 (3), 376. doi:10.1016/0924-977X(92)90229-2
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Growth hormone response to apomorphine test in retarded vs agitated depressed patients. European Neuropsychopharmacology, 2 (3), 307-308. doi:10.1016/0924-977X(92)90145-X
Peer Reviewed verified by ORBi

ANSSEAU, M., PAPART, P., PITCHOT, W., Timsit-Berthier, M., Legros, J.-J., & von Frenckell, R. (1992). Dexamethasone suppression test and prediction of treatment response to selective antidepressants. European Psychiatry, 7 (4), 191-194.
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrinienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204.
Peer reviewed

ANSSEAU, M., PITCHOT, W., Gonzalez-Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1992). Flesinoxan, a 5-HT1A agonist, in major depression: Clinical efficacy and effects on rem latency and body temperature (open study). European Neuropsychopharmacology, 2 (3), 313. doi:10.1016/0924-977X(92)90153-Y
Peer Reviewed verified by ORBi

Ansseau, M., Pitchot, W., Hansenne, M., & Gonzalez Moreno, A. (1992). Psychotic reactions to zolpidem. The Lancet, 339 (8796), 809. doi:10.1016/0140-6736(92)91935-2
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204.
Peer reviewed

PITCHOT, W., Gonzalez Moreno, A., Ansseau, M., Hansenne, M., & Papart, P. (1992). Clonidine test in bipolar vs unipolar melancholic patients. European Neuropsychopharmacology, 2 (3), 306. doi:10.1016/0924-977X(92)90142-U
Peer Reviewed verified by ORBi

PITCHOT, W., Ansseau, M., Réel, C., Gonzalez Moreno, A., Papart, P., & Hansenne, M. (1992). Red blood cell folate and suicidal behavior. European Neuropsychopharmacology, 2 (3), 306-307. doi:10.1016/0924-977X(92)90143-V
Peer Reviewed verified by ORBi

Schittecatte, M., ANSSEAU, M., Charles, G., Machowski, R., Papart, P., PITCHOT, W., & Wilmotte, J. (1992). Growth hormone response to clonidine in male untreated panic patients. Psychological Medicine, 22 (4), 1059-1062. doi:10.1017/s0033291700038630
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1992). Therapeutic window for 5-HT reuptake inhibitors. The Lancet, 339 (8794). doi:10.1016/0140-6736(92)90858-Z
Peer Reviewed verified by ORBi

PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Relationship between clonidine test and suicidal behavior. European Neuropsychopharmacology, 2 (3), 307. doi:10.1016/0924-977X(92)90144-W
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1992). Dopaminergic function in panic disorder: comparison with major and minor depression. Biological Psychiatry, 32 (11), 1004-1011. doi:10.1016/0006-3223(92)90061-4
Peer Reviewed verified by ORBi

Hansenne, M., PITCHOT, W., Gonzalez-Moreno, A., von Frenckell, R., & Ansseau, M. (1992). Clonidine test and MMPI scales in major depression : State or trait markers? European Psychiatry, 7 (3), 129-133.
Peer Reviewed verified by ORBi

ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, Hansenne, M., papart, P., Gerritsen Van Der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. Biological Psychiatry.
Peer Reviewed verified by ORBi

PITCHOT, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1991). Suicidal behavior and growth hormone response to apomorphine test. European Neuropsychopharmacology, 1 (3), 462. doi:10.1016/0924-977x(91)90681-j
Peer Reviewed verified by ORBi

PITCHOT, W., Hansenne, M., Charles, G., Machowski, R., ANSSEAU, M., Gonzalez Moreno, A., Schittecatte, M., Wilmotte, J., & Mirel, J. (1991). P300 in posttraumatic stress disorder: preliminary results. European Neuropsychopharmacology, 1 (3), 465-466. doi:10.1016/0924-977X(91)90687-P
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzales Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. European Neuropsychopharmacology, 1 (3), 436. doi:10.1016/0924-977x(91)90641-7
Peer Reviewed verified by ORBi

PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1991). Dopaminergic function in panic disorder. European Neuropsychopharmacology, 1 (3), 464. doi:10.1016/0924-977x(91)90685-n
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., & Ansseau, M. (1991). The clonidine test in posttraumatic stress disorder. American Journal of Psychiatry, 148 (6), 810-811. doi:10.1176/ajp.148.6.810b
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., & Ansseau, M. (1991). The lack of relationship between DST nonsuppression in the dexamethasone suppression test and EEG abnormalities. European Archives of Psychiatry and Clinical Neuroscience, 241 (3), 193-4. doi:10.1007/BF02219721
Peer Reviewed verified by ORBi

Pitchot, W., Ansseau, M., & Franck, G. (December 1990). Aspects pratiques de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613.
Peer reviewed

Pitchot, W., Hansenne, M., Moreno, A. G., von Frenckell, R., & Ansseau, M. (1990). Psychopathological correlates of dopaminergic disturbances in major depression. Neuropsychobiology, 24 (4), 169-72. doi:10.1159/000119481
Peer Reviewed verified by ORBi

PITCHOT, W., & Ansseau, M. (1990). Aspects pratique de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613.
Peer reviewed

PITCHOT, W. (1989). Intérêt de l'EEG de sommeil dans les états dépressifs. Revue Médicale de Liège, 34, 187-191.
Peer reviewed

PITCHOT, W., ANSSEAU, M., PAPART, P., Franck, G., & Rorive, G. (1989). Hyponatrémie induite par la carbamazépine et affection rénale : à propos d'un cas. Psychiatrie et Psychobiologie, 4 (4), 235-237. doi:10.1017/S0767399X00002807
Peer Reviewed verified by ORBi

Contact ORBi